HUP0401910A3 - Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them - Google Patents

Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them

Info

Publication number
HUP0401910A3
HUP0401910A3 HU0401910A HUP0401910A HUP0401910A3 HU P0401910 A3 HUP0401910 A3 HU P0401910A3 HU 0401910 A HU0401910 A HU 0401910A HU P0401910 A HUP0401910 A HU P0401910A HU P0401910 A3 HUP0401910 A3 HU P0401910A3
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
novel use
substituted aminomethyl
aminomethyl chromans
Prior art date
Application number
HU0401910A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0401910A2 publication Critical patent/HUP0401910A2/hu
Publication of HUP0401910A3 publication Critical patent/HUP0401910A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
HU0401910A 2001-09-19 2002-08-12 Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them HUP0401910A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01122377 2001-09-19
PCT/EP2002/009001 WO2003024960A1 (en) 2001-09-19 2002-08-12 Novel use of substituted aminomethyl chromans

Publications (2)

Publication Number Publication Date
HUP0401910A2 HUP0401910A2 (hu) 2005-01-28
HUP0401910A3 true HUP0401910A3 (en) 2011-02-28

Family

ID=8178662

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0401910A HUP0401910A3 (en) 2001-09-19 2002-08-12 Novel use of substituted aminomethyl chromans and pharmaceutical compositions containing them

Country Status (25)

Country Link
US (1) US7618988B2 (hu)
EP (1) EP1427724B1 (hu)
JP (1) JP4615857B2 (hu)
KR (1) KR100912911B1 (hu)
CN (1) CN100338060C (hu)
AR (1) AR036677A1 (hu)
AT (1) ATE325120T1 (hu)
AU (1) AU2002331229B2 (hu)
BR (1) BR0212555A (hu)
CA (1) CA2460696C (hu)
CY (1) CY1105118T1 (hu)
DE (1) DE60211186T2 (hu)
DK (1) DK1427724T3 (hu)
ES (1) ES2262840T3 (hu)
HU (1) HUP0401910A3 (hu)
MX (1) MXPA04002492A (hu)
MY (1) MY128882A (hu)
PE (1) PE20030428A1 (hu)
PL (1) PL208787B1 (hu)
PT (1) PT1427724E (hu)
RU (1) RU2322443C2 (hu)
SI (1) SI1427724T1 (hu)
TW (1) TWI244391B (hu)
WO (1) WO2003024960A1 (hu)
ZA (1) ZA200402855B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10318690B3 (de) * 2003-04-24 2004-11-11 Merck Patent Gmbh Verfahren zur Herstellung von Nicotinaldehyden
FR2978916B1 (fr) 2011-08-10 2013-07-26 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
US10561618B2 (en) * 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
FR3001894A1 (fr) 2013-02-08 2014-08-15 Servier Lab Composition pharmaceutique solide pour administration buccale d'agomelatine
CN109689036A (zh) 2016-07-11 2019-04-26 康特拉医药公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5767132A (en) * 1980-10-07 1982-04-23 Nippon Steel Corp Vertical type continuous annealing furnace having independently moving middle partition plate
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
PL181385B1 (pl) * 1993-08-19 2001-07-31 Janssen Pharmaceutica Nv Nowe pochodne dihydrobenzopiranu o wlasciwosciach naczyniozwezajacych, kompozycja farmaceutyczna i sposób wytwarzania pochodnych dihydrobenzopiranu PL PL PL PL PL PL
DK0707007T3 (da) * 1994-10-14 2002-03-18 Merck Patent Gmbh Amino(thio)etherderivater som CNS-aktive midler
US5585388A (en) * 1995-04-07 1996-12-17 Sibia Neurosciences, Inc. Substituted pyridines useful as modulators of acetylcholine receptors
US5756521A (en) * 1996-04-03 1998-05-26 American Home Products Corporation Chroman-2-ylmethylamino derivatives
UA73981C2 (en) * 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit

Also Published As

Publication number Publication date
CN1714089A (zh) 2005-12-28
PL208787B1 (pl) 2011-06-30
CY1105118T1 (el) 2009-11-04
MXPA04002492A (es) 2004-05-31
PE20030428A1 (es) 2003-05-24
MY128882A (en) 2007-02-28
RU2322443C2 (ru) 2008-04-20
DK1427724T3 (da) 2006-08-21
ATE325120T1 (de) 2006-06-15
DE60211186D1 (de) 2006-06-08
ES2262840T3 (es) 2006-12-01
JP2005527476A (ja) 2005-09-15
CA2460696C (en) 2011-01-11
SI1427724T1 (sl) 2006-10-31
EP1427724B1 (en) 2006-05-03
KR20040044461A (ko) 2004-05-28
AR036677A1 (es) 2004-09-29
US7618988B2 (en) 2009-11-17
BR0212555A (pt) 2004-10-19
CA2460696A1 (en) 2003-03-27
EP1427724A1 (en) 2004-06-16
PT1427724E (pt) 2006-09-29
AU2002331229B2 (en) 2008-05-15
HUP0401910A2 (hu) 2005-01-28
PL369684A1 (en) 2005-05-02
KR100912911B1 (ko) 2009-08-20
JP4615857B2 (ja) 2011-01-19
CN100338060C (zh) 2007-09-19
ZA200402855B (en) 2005-01-14
RU2004112190A (ru) 2005-05-10
US20060229339A1 (en) 2006-10-12
DE60211186T2 (de) 2007-01-18
TWI244391B (en) 2005-12-01
WO2003024960A1 (en) 2003-03-27

Similar Documents

Publication Publication Date Title
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
IL192937A0 (en) Pharmaceutical compositions containing beta-lapachone or derivatives or analogs thereof, and methods of using same
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
HUP0303193A3 (en) Phthalayinone-piperidino-derivatives as pde4 inhibitors and pharmaceutical compositions containing them
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
HUP0400114A3 (en) N-benzoyl-benzenesulfonamid derivatives as antitumor agents and pharmaceutical compositions containing them
HUP0304058A2 (hu) Xa faktor szulfonamid-laktám inhibitorok és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
PL370855A1 (en) N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HUP0400245A3 (en) Somatostatin-dopamine chimeric analogs and pharmaceutical compositions containing them
HUP0400077A2 (hu) Deutériumozott 3-piperidino-propiofenon és a vegyületeket tartalmazó gyógyszerekészítmények
HUP0402510A3 (en) Nociceptin analogs and pharmaceutical compositions containing them
GB0108470D0 (en) Pharmaceutical compositions and their use
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
PL367128A1 (en) Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
GB0202900D0 (en) Novel formulations of drugs
AU2003297840A8 (en) Chemopreventive and therapeutic aspects of polyphenolic compositions and assays
HUP0400023A2 (hu) Új heterociklusos származékok és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
HUP0401204A3 (en) Novel immunomodulating heterocondensated pyrazol-3-one derivatives and pharmaceutical compositions containing them
HUP0401644A3 (en) Aminobenzoephenones, pharmaceutical compositions containing them and use thereof
HUP0303469A3 (en) Phtalazinon-derivatives, their use and pharmaceutical compositions containing them
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished